Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy

A. Naing; K. A. Autio; G. S. Falchook; F. Meric-Bernstam; J. K. Litton; N. K. Ibrahim; A. Hung; M. Oft; J. Leveque; M. R. Patel

doi:10.1093/annonc/mdy288.018

Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy

A. Naing, K. A. Autio, G. S. Falchook, F. Meric-Bernstam, J. K. Litton, N. K. Ibrahim, A. Hung, M. Oft, J. Leveque, M. R. Patel

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii407-viii408
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy288.018
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy288.018

Cite this

Naing, A., Autio, K. A., Falchook, G. S., Meric-Bernstam, F., Litton, J. K., Ibrahim, N. K., Hung, A., Oft, M., Leveque, J., & Patel, M. R. (2018). Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii407-viii408. https://doi.org/10.1093/annonc/mdy288.018

Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. / Naing, A.; Autio, K. A.; Falchook, G. S. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii407-viii408.

Research output: Contribution to journal › Article › peer-review

Naing, A, Autio, KA, Falchook, GS, Meric-Bernstam, F , Litton, JK , Ibrahim, NK, Hung, A, Oft, M, Leveque, J & Patel, MR 2018, 'Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii407-viii408. https://doi.org/10.1093/annonc/mdy288.018

Naing A, Autio KA, Falchook GS, Meric-Bernstam F , Litton JK , Ibrahim NK et al. Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii407-viii408. doi: 10.1093/annonc/mdy288.018

@article{b5da983b609f4d47b99324e152071820,

title = "Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy",

author = "A. Naing and Autio, {K. A.} and Falchook, {G. S.} and F. Meric-Bernstam and Litton, {J. K.} and Ibrahim, {N. K.} and A. Hung and M. Oft and J. Leveque and Patel, {M. R.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy288.018",

language = "English (US)",

volume = "29",

pages = "viii407--viii408",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy

AU - Naing, A.

AU - Autio, K. A.

AU - Falchook, G. S.

AU - Meric-Bernstam, F.

AU - Litton, J. K.

AU - Ibrahim, N. K.

AU - Hung, A.

AU - Oft, M.

AU - Leveque, J.

AU - Patel, M. R.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081957440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081957440&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy288.018

DO - 10.1093/annonc/mdy288.018

M3 - Article

C2 - 32137019

SN - 0923-7534

VL - 29

SP - viii407-viii408

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this